NEXPOINT ASSET MANAGEMENT, L.P. - AMRYT PHARMA PLC ownership

AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 57 filers reported holding AMRYT PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 1.2%.

Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of AMRYT PHARMA PLC
ValueSharesWeighting
Q3 2022$277,000
-1.1%
40,0000.0%0.02%
-24.0%
Q2 2022$280,000
-15.4%
40,0000.0%0.02%
-41.9%
Q1 2022$331,000
-23.4%
40,0000.0%0.04%
-29.5%
Q4 2021$432,000
-10.7%
40,0000.0%0.06%
-26.5%
Q3 2021$484,000
-0.2%
40,0000.0%0.08%
-21.7%
Q2 2021$485,000
-56.5%
40,000
-50.0%
0.11%
-63.6%
Q1 2021$1,114,000
-1.6%
80,0000.0%0.29%
-21.8%
Q4 2020$1,132,00080,0000.37%
Other shareholders
AMRYT PHARMA PLC shareholders Q4 2022
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 8,857,268$61,292,00022.96%
Stonepine Capital Management, LLC 6,227,733$43,096,00019.37%
MPM ASSET MANAGEMENT LLC 2,668,843$18,468,0007.03%
Aquilo Capital Management, LLC 1,998,993$13,833,0004.99%
New Leaf Venture Partners, L.L.C. 449,737$3,112,0001.85%
Global Frontier Investments LLC 505,000$3,495,0001.77%
Rubric Capital Management LP 3,600,000$24,912,0001.26%
Telemetry Investments, L.L.C. 123,000$851,0001.09%
Nantahala Capital Management 1,437,458$9,947,0000.64%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 6,333,552$43,828,0000.62%
View complete list of AMRYT PHARMA PLC shareholders